Oksuzoglu Kevser, Ones Tunc, Ozguven Salih, Inanir Sabahat, Turoglu Halil Turgut, Bozkurtlar Emine, Celikel Cigdem Ataizi, Erdil Tanju Yusuf
Department of Nuclear Medicine.
Department of Pathology, Pendik Research and Training Hospital, Marmara University, Istanbul, Turkey.
Medicine (Baltimore). 2018 Oct;97(42):e12817. doi: 10.1097/MD.0000000000012817.
Delayed 18F-2-fluoro-2-deoxy-D-glucose (F-FDG) positron emission tomography (PET) imaging has been associated with improved diagnostic yield in several malignancies; however, data on the use of delayed imaging in patients with hepatocellular carcinoma (HCC) is scarce. This study aimed to examine tumoral and background standardized uptake value (SUV) alterations in dual-phase F-FDG PET/computed tomography (CT) imaging.Fifty-two HCC cases underwent dual-time-point F-FDG PET/CT examination where early and delayed images were obtained. The maximum and mean SUVs (SUVmax and SUVmean) of the tumor were determined for both time points. Similarly, the average SUVmean were also determined for background (liver, soft tissue, and spleen). Changes in tumoral and background SUV between early and delayed images were examined.The mean age was 62.0 ± 12.9 years (range, 20-88 years) and the majority of the patients were men (86.5%). Tumor SUVs, both tumor SUVmean and tumor SUVmax, significantly increased at delayed images when compared to early images. In contrast, the average SUVmean for the liver, soft tissue, and spleen significantly decreased at delayed images.A significant increase in tumor SUV in delayed images in contrast to a significant decrease in background SUVs suggests that delayed images in HCC may contribute to diagnostic performance through a potential increase in the contrast between the tumor and background. However, further studies with larger sample sizes including patients with benign lesions and different grades of the disease are warranted to better elucidate the diagnostic contribution as well as the association of delayed imaging values with prognosis.
延迟18F-2-氟-2-脱氧-D-葡萄糖(F-FDG)正电子发射断层扫描(PET)成像已与多种恶性肿瘤诊断率的提高相关;然而,关于肝细胞癌(HCC)患者使用延迟成像的数据却很稀少。本研究旨在检查双期F-FDG PET/计算机断层扫描(CT)成像中肿瘤和背景标准化摄取值(SUV)的变化。52例HCC患者接受了双时间点F-FDG PET/CT检查,获取了早期和延迟图像。确定了两个时间点肿瘤的最大和平均SUV(SUVmax和SUVmean)。同样,也确定了背景(肝脏、软组织和脾脏)的平均SUVmean。检查了早期和延迟图像之间肿瘤和背景SUV的变化。平均年龄为62.0±12.9岁(范围20-88岁),大多数患者为男性(86.5%)。与早期图像相比,延迟图像时肿瘤SUV,即肿瘤SUVmean和肿瘤SUVmax均显著增加。相比之下,延迟图像时肝脏、软组织和脾脏的平均SUVmean显著降低。延迟图像中肿瘤SUV显著增加而背景SUV显著降低,这表明HCC的延迟图像可能通过潜在增加肿瘤与背景之间的对比度而有助于诊断性能。然而,需要进一步开展更大样本量的研究,纳入良性病变患者和不同疾病分级的患者,以更好地阐明延迟成像的诊断贡献以及延迟成像值与预后的关联。